Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Resmed Inc. buy Bank of America Co.

Start price
€136.80
18.09.23 / 50%
Target price
€215.26
18.09.24
Performance (%)
47.98%
Price
€201.10
17.05.24
Summary
This prediction is currently active. With a performance of 47.98% the BUY prediction by Bank_of_America_Co_ is a big success. Dividends of €1.34 are taken into consideration when calculating the performance. This prediction currently runs until 18.09.24. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Resmed Inc. 1.310% 1.310%
iShares Core DAX® -0.383% 5.404%
iShares Nasdaq 100 1.248% 6.732%
iShares Nikkei 225® 0.525% 1.840%
iShares S&P 500 0.640% 4.710%

Comments by Bank_of_America_Co_ for this prediction

In the thread Resmed Inc. diskutieren
Prediction Buy
Perf. (%) 47.98%
Target price 215.257
Change
Ends at 18.09.24

ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Bank of America Co. from $250.00 to $230.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat